GREEN GENES
LIVE

Serial Number

98558948

Owner

Camena Bioscience Limited

Attorney

Jeffrey H. Greene

Filing Date

May 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GREEN GENES Trademark

Serial Number: 98558948

GREEN GENES is a trademark filed by Camena Bioscience Limited on May 20, 2024. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Camena Bioscience Limited (4 trademarks)

Little Chesterford
SAFFRON WALDEN, Essex CB101XL , GB

Entity Type: 16

Trademark Details

Filing Date

May 20, 2024

Registration Date

Not Registered

Goods & Services

Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; Synthetic DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for use in medical biologics and therapeutics; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins

Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; Genetic engineering services, namely, manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the design, development and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineering, namely, production of complex gene sequences; Consultancy, advisory and information services related to the aforementioned services

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 21, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 11, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 10, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 10, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 10, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 25, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2024 NWOS
NEW APPLICATION ENTERED
May 20, 2024 NWAP